Roivant Sciences Ltd. ROIV NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • GB • USD

SharesGrow Score

64/100

4/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Balance sheet is a point-in-time snapshot. TTM shows the most recent available quarter.

Metric	Latest Quarter (2025-12)
Total Assets	$5.23B
Total Liabilities	$251.14M
Total Debt	$207.44M
Cash & Investments	$4.53B
Total Stockholders Equity	$4.27B

People Also View

RVMD

Revolution Medicines, Inc.

Prometheus Biosciences, Inc.

$199.92

+0.09%

BPMC

Blueprint Medicines Corporation

$129.46

+0.14%

KRYS

Krystal Biotech, Inc.

$268.54

-0.54%

APLS

Apellis Pharmaceuticals, Inc.

$40.85

-0.01%

AKRO

Akero Therapeutics, Inc.

$54.65

+0.00%

Roivant Sciences Ltd. ROIV NASDAQ

People Also View

Get Undervalued Stock Alerts